» Download Public Reports
About 200 reports
- Industry report
- February 2013
- 32 pages
... But this system lacks mechanisms to carry out posttranslational modifications. Today, plants represent an alternative for production of recombinant proteins. As bioreactors, they offer the possibility ...
December 2012
... Which are used in the production of protein-based therapeutic products can be expected to slow down. However if development work continues, the products needed for complete single-use production systems ...
November 2012
... Represented by its new brand boehringer ingelheim bioxcellence . As a leading biopharmaceutical contract manufactu with more than 35 years of experience The company has brought 19 biopharmaceutical ...
November 2012
... Funding and the realignment of the company through the business combination with x-pol. With the marketing of the dna amplification technologies and products, sygnis is aiming ...
October 2012
... Listed sartorius stedim biotech. Swot analysis strengths weaknesses Leading market position in key product categories Pricing power in biotech: fragmented client base; consoli- dated supplier base ...
September 2012
... Of antibody fragments in manufacturing increasing production of antibody fragments in e. Coli by various strategies, such as vector design, strain engineering, co-expressing host cell proteins and process ...
July 2012
... Such as predicting cell line productivity, the advantage of pre-developed producer cells, key components of chemically defined cell culture media, and novel disposable and process intensification technologies. Thus ...
July 2012
... Such as predicting cell line productivity, the advantage of pre-developed producer cells, key components of chemically defined cell culture media, and novel disposable and process intensification technologies. Thus ...
July 2012
... Such as predicting cell line productivity, the advantage of pre-developed producer cells, key components of chemically defined cell culture media, and novel disposable and process intensification technologies. Thus ...
July 2012
... Stopped disease progression in an ae patient [13]. Th1- and th2-type immune responses in ae have exten- sively been studied, but pro-inflammatory and regulatory chemokines as well as th17-type cytokines ...
» Purchase Premium Reports
(From $ 250 - $ 2 488)
44 reports
- $ 2 488
- Industry report
- June 2013
- by MarketSizeInfo
Global Vaccine Market to 2017 - Market Size, Growth and Forecasts in Over 70 Countries is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market ...
May 2013
$ 250
Summary Emergent BioSolutions Inc. (Emergent) is a biopharmaceutical company. The company operates through two divisions, namely, Biodefense and Biosciences. The company's Biodefense division is directed ...
May 2013
$ 250
Summary R&D Biopharmaceuticals GmbH (R&D-Biopharmaceuticals) is a biotechnology company, based in Germany. The company centers on pre-clinical and clinical development of unique small molecules deriving ...
April 2013
$ 250
Summary c-LEcta GmbH (c-LEcta) is an industrial biotechnology company, based in Germany. The company develops and implements sustainable and economic industrial processes based on customized enzymes and ...
March 2013
$ 250
Summary Lophius Biosciences GmbH (Lophius) is a privately held biotechnology company, based in Germany. It researches, develops, and markets diagnostic products for acute infectious and autoimmune diseases. ...
